Review




Structured Review

GenMark Diagnostics respiratory pathogen nucleic acid test
Respiratory Pathogen Nucleic Acid Test, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogen+testing/respiratory+pathogen+nucleic+acid+test/pmc09671206-9820-81-91
Average 90 stars, based on 1 article reviews
respiratory pathogen nucleic acid test - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

Amplification:

Article Title: Antibody tests for identification of current and past infection with SARS‐CoV‐2
Article Snippet: Target condition and reference standard(s) , Reference standard: Positive for COVID‐19 by a nucleic acid amplification test that had been clinically validated in our laboratory and had an emergency use authorisation (EUA) listing with the US Food and Drug Administration Threshold not stated Samples used: Not stated Timing of reference standard: Not stated Blinded to index test: yes, prior to index test Incorporated index test: no Definition of non‐COVID cases: [2a], [2b] To identify patient specimens containing other PCR‐confirmed microbes, the respiratory pathogen nucleic acid (RPNA) test was performed on the GenMark ePlex. This panel detects Adenovirus (A‐F), coronavirus (229E, HKU1, NL63, OC42), human metapneumovirus, human rhinovirus/enterovirus, influenza A, B and C, influenza 2009 H1N1, parainfluenza (1‐4), respiratory syncytial virus (A and B), chlamydia pneumoniae and mycoplasma pneumoniae. [2c] Untested (no respiratory symptoms per self‐report) [2d] Pre‐pandemic Samples used: [2a] and [2b] Not stated or untested [2c] Untested [2d] Pre‐pandemic Timing of reference standard: Not stated Blinded to index test: yes, prior to index test Incorporated index test: no , , .

Polymerase Chain Reaction:

Article Title: Antibody tests for identification of current and past infection with SARS‐CoV‐2
Article Snippet: Target condition and reference standard(s) , Reference standard: Positive for COVID‐19 by a nucleic acid amplification test that had been clinically validated in our laboratory and had an emergency use authorisation (EUA) listing with the US Food and Drug Administration Threshold not stated Samples used: Not stated Timing of reference standard: Not stated Blinded to index test: yes, prior to index test Incorporated index test: no Definition of non‐COVID cases: [2a], [2b] To identify patient specimens containing other PCR‐confirmed microbes, the respiratory pathogen nucleic acid (RPNA) test was performed on the GenMark ePlex. This panel detects Adenovirus (A‐F), coronavirus (229E, HKU1, NL63, OC42), human metapneumovirus, human rhinovirus/enterovirus, influenza A, B and C, influenza 2009 H1N1, parainfluenza (1‐4), respiratory syncytial virus (A and B), chlamydia pneumoniae and mycoplasma pneumoniae. [2c] Untested (no respiratory symptoms per self‐report) [2d] Pre‐pandemic Samples used: [2a] and [2b] Not stated or untested [2c] Untested [2d] Pre‐pandemic Timing of reference standard: Not stated Blinded to index test: yes, prior to index test Incorporated index test: no , , .

Virus:

Article Title: Antibody tests for identification of current and past infection with SARS‐CoV‐2
Article Snippet: Target condition and reference standard(s) , Reference standard: Positive for COVID‐19 by a nucleic acid amplification test that had been clinically validated in our laboratory and had an emergency use authorisation (EUA) listing with the US Food and Drug Administration Threshold not stated Samples used: Not stated Timing of reference standard: Not stated Blinded to index test: yes, prior to index test Incorporated index test: no Definition of non‐COVID cases: [2a], [2b] To identify patient specimens containing other PCR‐confirmed microbes, the respiratory pathogen nucleic acid (RPNA) test was performed on the GenMark ePlex. This panel detects Adenovirus (A‐F), coronavirus (229E, HKU1, NL63, OC42), human metapneumovirus, human rhinovirus/enterovirus, influenza A, B and C, influenza 2009 H1N1, parainfluenza (1‐4), respiratory syncytial virus (A and B), chlamydia pneumoniae and mycoplasma pneumoniae. [2c] Untested (no respiratory symptoms per self‐report) [2d] Pre‐pandemic Samples used: [2a] and [2b] Not stated or untested [2c] Untested [2d] Pre‐pandemic Timing of reference standard: Not stated Blinded to index test: yes, prior to index test Incorporated index test: no , , .



Similar Products

99
ATCC test pathogenic bacteria
Test Pathogenic Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogen+testing/Bacteria/pm41599350-134-1-10
Average 99 stars, based on 1 article reviews
test pathogenic bacteria - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
ATCC test pathogens pseudomonas aeruginosa
Test Pathogens Pseudomonas Aeruginosa, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogen+testing/Pseudomonas%3B+aeruginosa/pmc12844374-112-1-22
Average 99 stars, based on 1 article reviews
test pathogens pseudomonas aeruginosa - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

96
Cellular Technology Ltd respiratory pathogens tst tuberculin skin test t spot t cell enzyme linked immunospot assay
Respiratory Pathogens Tst Tuberculin Skin Test T Spot T Cell Enzyme Linked Immunospot Assay, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogen+testing/Human+IFN-%CE%B3+Single-Color+ELISPOT/pm41398562-164-85-94
Average 96 stars, based on 1 article reviews
respiratory pathogens tst tuberculin skin test t spot t cell enzyme linked immunospot assay - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

86
Karius Inc karius test pathogen categories
Flow diagram depicting patient and sample selection for the comparison of BAL fluid mcfDNA sequencing with the <t>Karius®</t> <t>test</t> and standard of care testing.
Karius Test Pathogen Categories, supplied by Karius Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogen+testing/karius+spectrum/med_rxiv__2025__11__05__25339543-55-0-0
Average 86 stars, based on 1 article reviews
karius test pathogen categories - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Sansure Biotech Inc respiratory pathogens nucleic acid test kit
Prevalence of pathogens in mono-infection and co-infection in children with CAP during 2022 and 2023. ( A ) Positive proportion of viruses, viral-viral co-infections, viral-bacterial co-infections, bacterial-bacterial co-infections, and bacteria in different years. ( B and C ) Heatmap of the co-infection rate of <t>respiratory</t> pathogens in 2022 ( B ) and 2023 ( C ). The grid color represents the co-infection rate of respiratory pathogens among children with SCAP. A darker color indicates higher co-infection rates between the pair of pathogens.
Respiratory Pathogens Nucleic Acid Test Kit, supplied by Sansure Biotech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogen+testing/acid+kit+nucleic+pathogens+respiratory+test/pmc12584751-94-12-24
Average 86 stars, based on 1 article reviews
respiratory pathogens nucleic acid test kit - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

92
ATCC viral pathogens source test concentration adenovirus type 1 atcc 8 9 × 105 tcid50
Prevalence of pathogens in mono-infection and co-infection in children with CAP during 2022 and 2023. ( A ) Positive proportion of viruses, viral-viral co-infections, viral-bacterial co-infections, bacterial-bacterial co-infections, and bacteria in different years. ( B and C ) Heatmap of the co-infection rate of <t>respiratory</t> pathogens in 2022 ( B ) and 2023 ( C ). The grid color represents the co-infection rate of respiratory pathogens among children with SCAP. A darker color indicates higher co-infection rates between the pair of pathogens.
Viral Pathogens Source Test Concentration Adenovirus Type 1 Atcc 8 9 × 105 Tcid50, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogen+testing/Human+adenovirus+1/fda_document____cdrh_docs_slash_reviews_slash_k111387-270-0-8
Average 92 stars, based on 1 article reviews
viral pathogens source test concentration adenovirus type 1 atcc 8 9 × 105 tcid50 - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

Image Search Results


Flow diagram depicting patient and sample selection for the comparison of BAL fluid mcfDNA sequencing with the Karius® test and standard of care testing.

Journal: medRxiv

Article Title: Microbial cell-free DNA sequencing of bronchoalveolar lavage fluid improves diagnostic yield and may add clinical utility in immunocompromised patients with severe pneumonia

doi: 10.1101/2025.11.05.25339543

Figure Lengend Snippet: Flow diagram depicting patient and sample selection for the comparison of BAL fluid mcfDNA sequencing with the Karius® test and standard of care testing.

Article Snippet: Karius® Test Pathogen Categories: The operating characteristics of the Karius® BAL test have recently been submitted for publication.

Techniques: Selection, Comparison, Sequencing

Additive diagnostic value of BAL fluid mcfDNA sequencing with the Karius® test (KT-BAL) compared to standard of care (SOC) testing in immunocompromised patients with pneumonia. A) Number of organisms across all samples identified by either SOC alone, KT-BAL alone, or both techniques, split by KT-BAL category. B) Organisms identified exclusively by KT-BAL across all samples, split by KT-BAL category.

Journal: medRxiv

Article Title: Microbial cell-free DNA sequencing of bronchoalveolar lavage fluid improves diagnostic yield and may add clinical utility in immunocompromised patients with severe pneumonia

doi: 10.1101/2025.11.05.25339543

Figure Lengend Snippet: Additive diagnostic value of BAL fluid mcfDNA sequencing with the Karius® test (KT-BAL) compared to standard of care (SOC) testing in immunocompromised patients with pneumonia. A) Number of organisms across all samples identified by either SOC alone, KT-BAL alone, or both techniques, split by KT-BAL category. B) Organisms identified exclusively by KT-BAL across all samples, split by KT-BAL category.

Article Snippet: Karius® Test Pathogen Categories: The operating characteristics of the Karius® BAL test have recently been submitted for publication.

Techniques: Diagnostic Assay, Sequencing

Analysis of microbial read and human read values reported by the BAL fluid Karius® test (KT-BAL). A) Organisms that are identified in at least five samples by both KT-BAL and standard of care (SOC) testing and in at least five other samples by only KT-BAL have significantly lower microbial read values in the SOC + KT-BAL samples (Mann-Whitney U test, FDR < 0.05). B) KT-BAL microbial read values strongly correlate with culture quantities from SOC (Spearman’s rank correlation). C) KT-BAL human read values do not correlate with markers of host immune response (Spearman’s rank correlation).

Journal: medRxiv

Article Title: Microbial cell-free DNA sequencing of bronchoalveolar lavage fluid improves diagnostic yield and may add clinical utility in immunocompromised patients with severe pneumonia

doi: 10.1101/2025.11.05.25339543

Figure Lengend Snippet: Analysis of microbial read and human read values reported by the BAL fluid Karius® test (KT-BAL). A) Organisms that are identified in at least five samples by both KT-BAL and standard of care (SOC) testing and in at least five other samples by only KT-BAL have significantly lower microbial read values in the SOC + KT-BAL samples (Mann-Whitney U test, FDR < 0.05). B) KT-BAL microbial read values strongly correlate with culture quantities from SOC (Spearman’s rank correlation). C) KT-BAL human read values do not correlate with markers of host immune response (Spearman’s rank correlation).

Article Snippet: Karius® Test Pathogen Categories: The operating characteristics of the Karius® BAL test have recently been submitted for publication.

Techniques: MANN-WHITNEY

Patients for whom BAL fluid mcfDNA testing with the Karius® test (KT-BAL) identified Category One or Two organisms missed by standard of care (SOC) had significantly more cumulative intubation days compared to patients where KT-BAL and SOC were concordant for all Category One or Two organisms. Hospital length of stay, ICU length of stay, and ICU mortality were worse in the KT-BAL only group, but these differences were not significant (Mann-Whitney U test for continuous variables, Fisher’s exact test for mortality).

Journal: medRxiv

Article Title: Microbial cell-free DNA sequencing of bronchoalveolar lavage fluid improves diagnostic yield and may add clinical utility in immunocompromised patients with severe pneumonia

doi: 10.1101/2025.11.05.25339543

Figure Lengend Snippet: Patients for whom BAL fluid mcfDNA testing with the Karius® test (KT-BAL) identified Category One or Two organisms missed by standard of care (SOC) had significantly more cumulative intubation days compared to patients where KT-BAL and SOC were concordant for all Category One or Two organisms. Hospital length of stay, ICU length of stay, and ICU mortality were worse in the KT-BAL only group, but these differences were not significant (Mann-Whitney U test for continuous variables, Fisher’s exact test for mortality).

Article Snippet: Karius® Test Pathogen Categories: The operating characteristics of the Karius® BAL test have recently been submitted for publication.

Techniques: MANN-WHITNEY

Prevalence of pathogens in mono-infection and co-infection in children with CAP during 2022 and 2023. ( A ) Positive proportion of viruses, viral-viral co-infections, viral-bacterial co-infections, bacterial-bacterial co-infections, and bacteria in different years. ( B and C ) Heatmap of the co-infection rate of respiratory pathogens in 2022 ( B ) and 2023 ( C ). The grid color represents the co-infection rate of respiratory pathogens among children with SCAP. A darker color indicates higher co-infection rates between the pair of pathogens.

Journal: Microbiology Spectrum

Article Title: Changing patterns of respiratory pathogens in hospitalized children with community-acquired pneumonia in northern China following the lifting of non-pharmaceutical interventions

doi: 10.1128/spectrum.01279-25

Figure Lengend Snippet: Prevalence of pathogens in mono-infection and co-infection in children with CAP during 2022 and 2023. ( A ) Positive proportion of viruses, viral-viral co-infections, viral-bacterial co-infections, bacterial-bacterial co-infections, and bacteria in different years. ( B and C ) Heatmap of the co-infection rate of respiratory pathogens in 2022 ( B ) and 2023 ( C ). The grid color represents the co-infection rate of respiratory pathogens among children with SCAP. A darker color indicates higher co-infection rates between the pair of pathogens.

Article Snippet: Multiplex fluorescent PCR assays were performed to detect bacterial pathogens using the Respiratory Pathogens Nucleic Acid Test Kit in accordance with the manufacturer’s instructions (Sansure Biotech, Changsha, China).

Techniques: Infection, Bacteria